Image source: Getty Images.
It hasn’t been a great year so far for Pacific Biosciences of California (NASDAQ: PACB). Shares of the genetic-sequencing company have dropped more than 35% in 2016. Pacific Biosciences announced its third-quarter results after the market closed on Wednesday. Were those results good enough to help the company turn things around? Here are the highlights.